Zobrazeno 1 - 10
of 136
pro vyhledávání: '"A. S. ARTEMYEVA"'
Autor:
R. M. Paltuev, O. A. Volynshchikova, Sh. R. Abdullaeva, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, Yu. A. Belaya, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, A. Yu. Vorontsov, E. A. Gaysina, A. A. Gofman, V. N. Dmitriev, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinova, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, A. S. Chichkanova, L. A. Churilova, M. V. Shomova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 30-36 (2023)
Background. Individual molecular characteristics of a tumor can serve as a basis for a tailored approach to therapy, prediction of the disease course and outcome, and timely treatment correction in cancer patients. Tumor genomic profiling allows for
Externí odkaz:
https://doaj.org/article/bb685938706842a0aee783498c6077ee
Autor:
R. M. Paltuev, A. G. Kudaybergenova, V. F. Semiglazov, A. S. Artemyeva, T. Yu. Semiglazova, A. V. Komyakhov, O. A. Volynshchikova, V. V. Klimenko, M. M. Urezkova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 56-68 (2023)
Aim. To increase the efficacy of systemic breast cancer therapy and reduce inappropriate prescriptions using individual immunohistochemical tumor characteristics, as well as to develop prognostic scales to ensure a tailored approach to adjuvant syste
Externí odkaz:
https://doaj.org/article/0912cd61a86340dd8c2b80d35f9f8d94
Autor:
R. M. Paltuev, S. N. Aleksakhina, A. S. Artemyeva, E. A. Baychorov, S. Yu. Bakharev, A. A. Bozhok, V. A. Vasin, V. I. Vladimirov, O. A. Volynshchikova, A. Yu. Vorontsov, E. A. Gaysina, A. A. Hoffman, E. N. Imyanitov, V. V. Klimenko, A. V. Komyakhov, M. M. Konstantinovа, M. V. Kopp, A. G. Kudaybergenova, I. A. Lalak, D. L. Matevosyan, N. M. Mudzhiri, O. V. Poltareva, O. I. Sevryukova, V. F. Semiglazov, T. Yu. Semiglazova, M. M. Urezkova, L. A. Churilova
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 69-81 (2023)
Background. Breast cancer is one of the most common female malignancies. Molecular diagnostic methods of tumor profiling allow us to analyze individual tumor characteristics, identify new prognostic and predictive markers. Aim. To increase the effica
Externí odkaz:
https://doaj.org/article/cc538d9ba3a84480917cd97d5f495115
Autor:
D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, E. K. Zhiltsova, R. V. Donskikh, A. P. Sokolenko, L. F. Shaykhelislamova, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, S. S. Ereshchenko, R. M. Paltuev, A. A. Bessonov, A. S. Artemyeva, R. S. Pesotskiy, N. S. Amirov, A. S. Emelyanov, V. V. Mortada, Ya. I. Bondarchuk, V. V. Semiglazov, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 48-55 (2023)
Background. BRCA-associated triple negative breast cancer (TNBC) is considered one of the most aggressive subtypes of breast cancer with high sensitivity to chemotherapy, which leads to increased interest in finding new treatment options for patients
Externí odkaz:
https://doaj.org/article/f7969acdde894223bd4331d72b66866d
Autor:
Ya. I. Bondarchuk, E. K. Zhiltsova, P. V. Krivorotko, R. S. Pesotskiy, A. S. Emelyanov, T. T. Tabagua, L. P. Gigolaeva, S. S. Yereshchenko, A. V. Komyakhov, K. S. Nikolaev, K. Yu. Zernov, V. V. Semiglazov, R. M. Paltuev, V. V. Mortada, L. F. Shaykhelislamova, D. A. Enaldieva, N. S. Amirov, V. S. Channov, A. S. Artemyeva, A. V. Chernaya, R. Kh. Ulyanova, V. F. Semiglazov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 4, Pp 43-51 (2023)
Background. Surgery is fundamental in complex and combined approach in the treatment of the early breast cancer. It is a common fact, that absence of tumor cells in the resection margin is the main indicator of oncological safety of the breast-conser
Externí odkaz:
https://doaj.org/article/b0b1ea7f79e54b3197715ab491a1c07a
Autor:
D. S. Plevako, M. S. Knyazeva, E. I. Sidina, M. V. Berkut, S. A. Reva, S. S. Tolmachev, A. S. Artemyeva, A. K. Nosov, A. V. Malek
Publikováno v:
Vestnik Urologii, Vol 10, Iss 4, Pp 98-108 (2023)
Introduction. A combination of antiandrogen and cytostatic drugs was justified in the neoadjuvant therapy of patients with high-risk prostate cancer (HiRPCa) in some clinical trials. The effectiveness of such therapy in each individual case depends o
Externí odkaz:
https://doaj.org/article/6fef6f155e154d7dbe7e8f8f0f30be65
Autor:
P. V. Krivorotko, V. V. Mortada, R. S. Pesotskiy, A. S. Artemyeva, A. S. Emelyanov, S. S. Ereshchenko, G. A. Dashyan, N. S. Amirov, T. T. Tabagua, L. P. Gigolaeva, A. V. Komyakhov, K. S. Nikolaev, M. M. Mortada, K. Yu. Zernov, E. K. Zhiltsova, V. O. Smirnova, Ya. I. Bondarchuk, D. A. Enaldieva, S. N. Novikov, E. A. Busko, A. V. Chernaya, P. I. Krzhivitskiy, R. M. Paltuev, T. Yu. Semiglazova, V. F. Semiglazov, A. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 29-39 (2022)
Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exc
Externí odkaz:
https://doaj.org/article/1dba194b85a7496f8bacea07c8744896
Autor:
E. A. Ulrikh, E. L. Dikareva, A. D. Dzharbaeva, O. A. Zhamborova, T. M. Pervuninа, E. V. Komlichenko, S. A. Protsenko, G. M. Teletaeva, O. A. Li, A. S. Artemyeva, I. A. Mashenko, G. F. Kutusheva, T. Yu. Semiglazova, А. F. Urmancheeva
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 112-117 (2022)
Trophoblastic neoplasias are rare tumors, accounting for less than 1 % of malignant neoplasms of the female genital tract. Trophoblastic tumors associated with developing pregnancy are extremely rare. The article presents the successful experience of
Externí odkaz:
https://doaj.org/article/aca41088b8854a62a107554883917393
Autor:
N. S. Popova, S. N. Novikov, P. I. Krzhivitskiy, L. A. Zhukova, P. V. Krivorotko, A. S. Artemyeva, A. E. Michnin, A. A. Valitova, V. V. Danilov, A. V. Chyornaya, T. T. Tabagua, Zh. V. Bryantseva, I. A. Akulova, S. V. Kanaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 18, Iss 3, Pp 14-23 (2022)
Background. The accurate and early diagnosis of breast cancer can improve efficacy of the treatment. The standard diagnostic methods such as mammography, ultrasound, and magnetic resonance tomography have a pivotal role in the detection of breast tum
Externí odkaz:
https://doaj.org/article/f1d4d88effda42879ae3f5e950e4a944
Autor:
A. K. Koviazin, L. V. Filatova, I. S. Zyuzgin, A. S. Artemyeva, M. S. Motalkina, Yu. A. Chudinovskikh, E. V. Dobrovolskaya, S. A. Volchenkov, I. L. Polyatskin, S. A. Shalaev, I. V. Ishmatova, A. A. Zverkova, D. S. Burda, S. S. Elkhova, T. Yu. Semiglazova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 104-116 (2022)
Introduction. Diffuse large B-cell lymphoma (DLBCL) is the most common (30-35%) type of B-cell lymphomas. Only about 60% of all newly diagnosed advanced-stage DLBCL can be completely treated by x6 CHOP-R only. High dose chemotherapy (HDCT) followed b
Externí odkaz:
https://doaj.org/article/9e2cca6dd1294807a4aa309975c44b15